You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. Stocks
  2. Iradimed Corp
  3. Swot
swot-logo

Iradimed Corp SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Iradimed Corp has 19 Strengths, 3 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

MACD Crossover Above Signal Line

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Increasing Revenue every Quarter for the past 8 Quarters

MACD crossed above signal line previous end of day

Increasing Revenue every Quarter for the past 4 Quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Increasing profits every quarter for the past 3 quarters

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

RSI indicating price weakness

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks